Posted inBusiness How to Invest Rs 20 Lakh: SIP vs Lumpsum vs STP Strategy Wondering how to invest Rs 20 lakh? Compare SIP, lumpsum, and STP investment strategies to choose the best approach for your financial goals. Posted by srkanalytics.srk@gmail.com October 8, 2026
Posted inBusiness Understanding SEBI Sectoral Debt Funds: Yields, Taxation and Risks Explore SEBI's new sectoral debt funds. Learn how these concentrated fixed-income options offer high yields, tax rules, and risk factors. Posted by srkanalytics.srk@gmail.com October 7, 2026
Posted inBusiness EPF Vs SIP: The Best Choice For Your Rs 10000 Monthly Investment Compare EPF and SIP to decide where to invest your Rs 10,000 monthly for long-term wealth creation, balancing safety and high growth potential. Posted by srkanalytics.srk@gmail.com October 7, 2026
Posted inBusiness Rs 10,000 SIP vs Rs 10 Lakh Lumpsum: Which Strategy Builds More Wealth Over 20 Years? Compare a Rs 10,000 SIP and a Rs 10 Lakh lumpsum investment over 20 years to discover which strategy generates superior long-term financial growth. Posted by srkanalytics.srk@gmail.com October 6, 2026
Posted inBusiness Consistency Versus Market-Beating Returns: Finding the Right Investment Strategy Discover the fundamental trade-off between market-beating returns and consistency in mutual fund investing to build a balanced portfolio. Posted by srkanalytics.srk@gmail.com October 2, 2026
Posted inBusiness How Institutional Investors Are Rewriting India IPO Strategies Explore how mutual funds and global institutions are reshaping India initial public offerings, demanding better price discovery and market segmentation. Posted by srkanalytics.srk@gmail.com October 1, 2026
Posted inBusiness Rs 25,000 Monthly SIP Growth: Wealth Creation Over 10, 20, and 30 Years Discover how a Rs 25,000 monthly SIP can grow over 10, 20, and 30 years through the power of compounding and rupee-cost averaging. Posted by srkanalytics.srk@gmail.com September 28, 2026
Posted inBusiness Fosun Pharma Sells 6 Percent Stake in Gland Pharma for 2800 Crore Rupees Fosun Pharma reduces its stake in Gland Pharma to 45.77 percent through a major block deal worth 2800 crore rupees with top institutional buyers. Posted by srkanalytics.srk@gmail.com September 26, 2026
Posted inBusiness PPFAS GIFT Lowers Minimum Investment for Global Funds to 500 Dollars PPFAS GIFT has reduced the minimum investment requirement for international funds from 5,000 dollars to 500 dollars, expanding access. Posted by srkanalytics.srk@gmail.com September 6, 2026